Skip to main content

Advertisement

SpringerLink
Log in

Wait-and-see-Strategie bei klinischem vollständigem Ansprechen nach Radiochemotherapie bei Rektumkarzinomen

Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer

  • Journal Club
  • Published:
coloproctology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Habr-Gama A, Perez RO, Nadalin W et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240(4):711–717 (discussion 717–718)

    PubMed  Google Scholar 

  2. Maas M, Beets-Tan RGH, Lambregts DMJ et al (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29(35):4633–4640

    Article  PubMed  Google Scholar 

  3. Sauer R, Liersch T, Merkel S et al (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 Randomized Phase III Trial after a median follow-up of 11 years. J Clin Oncol 30(16):1926–1933

    Article  PubMed  CAS  Google Scholar 

  4. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731–1740

    Article  PubMed  CAS  Google Scholar 

  5. Rödel C, Liersch T, Becker H et al (2012) Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol 13(7):679–687

    Article  PubMed  Google Scholar 

  6. Maas M, Nelemans PJ, Valentini V et al (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11(9):835–844

    Article  PubMed  Google Scholar 

  7. Martin ST, Heneghan HM, Winter DC (2012) Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg 99(7):918–928

    Article  PubMed  CAS  Google Scholar 

  8. Glynne-Jones R, Hughes R (2012) Critical appraisal of the „wait and see“ approach in rectal cancer for clinical complete responders after chemoradiation. Br J Surg 99(7):897–909

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Klinik für Viszeral-, Gefäß- und Transplantationschirurgie, Krankenhaus Merheim der Städtischen Kliniken Köln, Klinikum der Universität Witten/Herdecke, Ostmerheimer Str. 200, 51109, Köln, Deutschland

    R. Siegel

Authors
  1. R. Siegel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Siegel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Siegel, R. Wait-and-see-Strategie bei klinischem vollständigem Ansprechen nach Radiochemotherapie bei Rektumkarzinomen. coloproctology 34, 375–376 (2012). https://doi.org/10.1007/s00053-012-0311-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00053-012-0311-7

Search

Navigation